Eli Lilly’s sales had fallen for six quarters in a row as a slew of patent expiries over the past three years slashed demand for its biggest products.

Eli Lilly’s quarterly sales rose for the first time in seven quarters, helped by demand for its new diabetes and cancer drugs as well as the acquisiti(...)

Drugs that could be the “first” to slow the progression of Alzheimer’s disease have been unveiled on Wednesday. Researchers revealed the promising res(...)

Immunocore, which was spun out of Oxford University in 2008, is developing novel T cell receptor (TCR) based therapies with the potential to treat a variety of cancers, viral infections and autoimmune diseases

Malin, the Irish-based company set up by a number of former Elan executives to invest in privately held life science assets, has invested $80 million (...)

Eli Lilly’s plant in Cork . US regulator is concerned over experimental lung cancer drug.

Eli Lilly ’s experimental lung cancer drug raised concerns with US regulators that it may increase patients’ risk of suffering potentially deadly blo(...)

 Royal Dutch Shell chief executive Ben van Beurden. In London, the company’s shares fell 2.1 per cent, trimming nearly 10 points off the FTSE 100.  Photograph:  Benoit Tessier/Reuters

European stocks slid, erasing a weekly gain, amid increasing concern that Greece’s efforts to renegotiate its debt and stay in the single currency (...)

The announcement of up to 70 jobs losses at Elanco in the Finisklin Industrial Estate in Sligo has been described as a devastating blow by local business leaders and politicians. Image: Google Maps.

The announcement of up to 70 jobs losses at Elanco in Sligo has been described as a devastating blow by local business leaders and politicians.The glo(...)

Despite higher than expected earnings, Eli Lilly is looking for its next big hit after coming off what it  called its worst year of sales, with patents expiring for top treatments.

Eli Lilly has reported first-quarter earnings that beat analysts’ estimates as the company increased sales of new medications such as cancer drug Cyr(...)

Swiss drug maker reported first-quarter profits beating estimates with operating income of $3.55 billion. Photograph: Reuters.

Novartis, the world’s biggest drugmaker by sales, reported first-quarter profits that beat analysts’ estimates as the company begins to benefit from a(...)

Domino’s Pizza: results out Thursday. Photograph: REUTERS/Luke MacGregor
For your diary

TODAY Results: Hasbro; M&T Bank; Morgan Stanley; Sanmina. Indicators: Euro zone construction output (Feb); US Chicago Fed national activity index (...)

Pfizer and Eli Lilly will resume a late-stage study testing their pain drug tanezumab after the US Food and Drug Administration lifted a partial hold (...)